A new study from the University of Michigan Rogel Health Cancer Center, published in Science , sheds light on how two ...

Overall survival was analyzed in real-world patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223.

MSD and Daiichi Sankyo have announced first subject dosing in the IDeate-Prostate01 Phase III trial of ifinatamab deruxtecan ...

BlackDoctor Foundation & AstraZeneca unite to fight cancer & lupus. Hear inspiring survivor stories and learn about early ...

Kevin Wilson and Wendy Wilson, who have been married for 19 years and share four children, both received stage 4 cancer ...

Prostate cancer was the most prevalent type among male survivors, affecting more than 3.5 million men in the US, followed by melanoma (n = 816,580) and colorectal cancer (n = 729,550).

George Evans had the opportunity of a lifetime as he stepped up to the mound to throw the first pitch at the Athletics game against the Houston Astros ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced ...

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and quality of life for patients. The FDA has approved darolutamide (Nubeqa ...